Logo image of UBXG

U-BX TECHNOLOGY LTD (UBXG) Stock Fundamental Analysis

NASDAQ:UBXG - Nasdaq - KYG9161K1040 - Common Stock - Currency: USD

3.5  +0.48 (+15.89%)

After market: 3.405 -0.1 (-2.71%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to UBXG. UBXG was compared to 82 industry peers in the IT Services industry. While UBXG seems to be doing ok healthwise, there are quite some concerns on its profitability. UBXG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

UBXG had negative earnings in the past year.
In the past year UBXG has reported a negative cash flow from operations.
In the past 5 years UBXG reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: UBXG reported negative operating cash flow in multiple years.
UBXG Yearly Net Income VS EBIT VS OCF VS FCFUBXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

With a Return On Assets value of -5.75%, UBXG is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
UBXG's Return On Equity of -6.96% is in line compared to the rest of the industry. UBXG outperforms 43.59% of its industry peers.
Industry RankSector Rank
ROA -5.75%
ROE -6.96%
ROIC N/A
ROA(3y)-0.14%
ROA(5y)-1.01%
ROE(3y)2.82%
ROE(5y)-7.14%
ROIC(3y)N/A
ROIC(5y)N/A
UBXG Yearly ROA, ROE, ROICUBXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Gross Margin of UBXG (1.57%) is worse than 96.15% of its industry peers.
UBXG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for UBXG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
UBXG Yearly Profit, Operating, Gross MarginsUBXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 1 -1

More info and screens

6

2. Health

2.1 Basic Checks

UBXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
UBXG has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for UBXG is higher compared to a year ago.
UBXG Yearly Shares OutstandingUBXG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
UBXG Yearly Total Debt VS Total AssetsUBXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 6.87 indicates that UBXG is not in any danger for bankruptcy at the moment.
UBXG's Altman-Z score of 6.87 is amongst the best of the industry. UBXG outperforms 82.05% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that UBXG is not too dependend on debt financing.
UBXG's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. UBXG outperforms 79.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 6.87
ROIC/WACCN/A
WACC9.01%
UBXG Yearly LT Debt VS Equity VS FCFUBXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

UBXG has a Current Ratio of 5.75. This indicates that UBXG is financially healthy and has no problem in meeting its short term obligations.
UBXG's Current ratio of 5.75 is amongst the best of the industry. UBXG outperforms 96.15% of its industry peers.
A Quick Ratio of 5.75 indicates that UBXG has no problem at all paying its short term obligations.
UBXG has a Quick ratio of 5.75. This is amongst the best in the industry. UBXG outperforms 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 5.75
Quick Ratio 5.75
UBXG Yearly Current Assets VS Current LiabilitesUBXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

UBXG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -579.21%.
The Revenue for UBXG has decreased by -46.36% in the past year. This is quite bad
Measured over the past years, UBXG shows a very negative growth in Revenue. The Revenue has been decreasing by -10.66% on average per year.
EPS 1Y (TTM)-579.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-488.72%
Revenue 1Y (TTM)-46.36%
Revenue growth 3Y-10.66%
Revenue growth 5YN/A
Sales Q2Q%-45.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UBXG Yearly Revenue VS EstimatesUBXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
UBXG Yearly EPS VS EstimatesUBXG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UBXG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBXG Price Earnings VS Forward Price EarningsUBXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UBXG Per share dataUBXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for UBXG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

U-BX TECHNOLOGY LTD

NASDAQ:UBXG (2/21/2025, 8:00:01 PM)

After market: 3.405 -0.1 (-2.71%)

3.5

+0.48 (+15.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners71.12%
Ins Owner ChangeN/A
Market Cap6.51M
AnalystsN/A
Price TargetN/A
Short Float %14.41%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS43.49
BVpS7.46
TBVpS7.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -6.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.57%
FCFM N/A
ROA(3y)-0.14%
ROA(5y)-1.01%
ROE(3y)2.82%
ROE(5y)-7.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
F-Score2
Asset Turnover4.82
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 174.93%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.75
Quick Ratio 5.75
Altman-Z 6.87
F-Score2
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)156.74%
Cap/Depr(5y)154.22%
Cap/Sales(3y)0.01%
Cap/Sales(5y)0.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-579.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-488.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-46.36%
Revenue growth 3Y-10.66%
Revenue growth 5YN/A
Sales Q2Q%-45.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-310.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-377.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-377.87%
OCF growth 3YN/A
OCF growth 5YN/A